menu
    • menu

    Company profile for 111

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    111, Inc. listed on NASDAQ (YI:US) is a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services in China. The Company provides millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy 1 Drugstore and indirectly through its offline virtual pharmacy network. The Company also offers online h...
    111, Inc. listed on NASDAQ (YI:US) is a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services in China. The Company provides millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy 1 Drugstore and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service and patient management service.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    111China Flag
    Country
    Country
    China
    Address
    Address
    Shanghai
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://ir.111.com.cn/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    111 Announces Q3 2025 Unaudited Financial Results
    111 Announces Q3 2025 Unaudited Financial Results

    17 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/111-inc-announces-third-quarter-2025-unaudited-financial-results-302644313.html

    PR NEWSWIRE
    17 Dec 2025
    Share Share
    111 Announces Second Quarter 2025 Unaudited Financial
    111 Announces Second Quarter 2025 Unaudited Financial

    17 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/111-inc-announces-second-quarter-2025-unaudited-financial-results-302558741.html

    PR NEWSWIRE
    17 Sep 2025
    Share Share
    CEL-SCI Announces Closing of $10 Million Public Offering
    CEL-SCI Announces Closing of $10 Million Public Offering

    29 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250829759392/en/CEL-SCI-Announces-Closing-of-%2410-Million-Public-Offering

    BUSINESSWIRE
    29 Aug 2025
    Share Share
    Hansa Biopharma reports Q2 and Jan-June 2025 financial results
    Hansa Biopharma reports Q2 and Jan-June 2025 financial results

    17 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hansa-biopharma-reports-second-quarter-and-interim-january-june-2025-financial-results-302507679.html

    PR NEWSWIRE
    17 Jul 2025
    Share Share
    111 Reveals Q1 2025 Unaudited Financial Results
    111 Reveals Q1 2025 Unaudited Financial Results

    19 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/111-inc-announces-first-quarter-2025-unaudited-financial-results-302486103.html

    PR NEWSWIRE
    19 Jun 2025
    Share Share
    111 Announces Q4 & 2024 Financial Results
    111 Announces Q4 & 2024 Financial Results

    19 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/111-inc-announces-fourth-quarter-and-fiscal-year-2024-financial-results-302406711.html

    PR NEWSWIRE
    19 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search